Thymosin Alpha-1 Activates Peritoneal Macrophages to Kill Tumor Cells

Thymosin alpha-1 activated peritoneal macrophages to become tumoricidal, increasing their production of reactive oxygen species and NO for direct cancer cell killing — additional evidence for macrophage-mediated antitumor immunity.

Shrivastava, Pratima et al.·Cancer investigation·2005·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01085Animal StudyPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Thymosin alpha-1 activated peritoneal macrophages to tumoricidal phenotype with increased reactive oxygen species and nitric oxide production, enabling direct tumor cell killing — confirming thymosin alpha-1's macrophage activation as a consistent antitumor mechanism.

Key Numbers

How They Did This

animal-study study on thymosin-alpha-1, cancer.

Why This Research Matters

Relevant for thymosin-alpha-1, cancer, immune-function.

The Bigger Picture

Advances peptide/biomarker research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Thymosin alpha-1 activated peritoneal macrophages to tumoricidal phenotype with increased reactive oxygen species and nitric oxide production, enablin
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
Antitumor activation of peritoneal macrophages by thymosin alpha-1.
Published In:
Cancer investigation, 23(4), 316-22 (2005)
Database ID:
RPEP-01085

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Thymosin Alpha-1 Activates Peritoneal Macrophages to Kill Tumor Cells

What was found?

Thymosin alpha-1 activated peritoneal macrophages to become tumoricidal, increasing their production of reactive oxygen species and NO for direct cancer cell killing — additional evidence for macrophage-mediated antitumor immunity.

Read More on RethinkPeptides

Cite This Study

RPEP-01085·https://rethinkpeptides.com/research/RPEP-01085

APA

Shrivastava, Pratima; Singh, Sukh Mahendra; Singh, Nisha. (2005). Antitumor activation of peritoneal macrophages by thymosin alpha-1.. Cancer investigation, 23(4), 316-22.

MLA

Shrivastava, Pratima, et al. "Antitumor activation of peritoneal macrophages by thymosin alpha-1.." Cancer investigation, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Antitumor activation of peritoneal macrophages by thymosin a..." RPEP-01085. Retrieved from https://rethinkpeptides.com/research/shrivastava-2005-antitumor-activation-of-peritoneal

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.